Applied Uv, INC 8-K filings

Applied UV, Inc. and its subsidiary SteriLumen, Inc. have filed for Chapter 11 bankruptcy, leading to the delisting of their stock from Nasdaq.

Applied UV, Inc. has been notified by Nasdaq for failing to file its quarterly report on time, potentially leading to delisting if a compliance plan is not accepted.

Applied UV, Inc. reports the resignations of two board members, Christopher Kochuba and Joseph Luhukay, effective May 21 and May 24, 2024, respectively.

Applied UV, Inc. has received a notice from Nasdaq stating that its common stock has failed to maintain the minimum $1.00 per share bid price, placing it at risk of delisting.

Applied UV, Inc. has announced the resignation of Mazars USA LLP as their independent registered public accounting firm, effective May 14, 2024.

Applied UV received a notice from Nasdaq for not meeting the minimum independent director requirement on its audit committee following a director's resignation.

Applied UV, Inc. has announced the resignations of three board members, including the Chairman, within a two-week period.

Applied UV, Inc. has announced that Mazars USA LLP will resign as their independent auditor, effective no later than May 31, 2024, with the company planning to engage a new firm.

Applied UV has amended its previous 8-K filing to provide additional details regarding the adjustment of warrant exercise prices following shareholder approval.

Applied UV, Inc. has successfully completed a $2.76 million registered direct and private placement offering to institutional investors.

Applied UV, Inc. has entered into a loan agreement for $772,500 with Cedar Advance LLC to support working capital and growth initiatives.

Applied UV, Inc. has appointed Christopher Kobucha as a new member of its Board of Directors, effective February 14, 2024.